NEWS - 22 June 2009
InferMed announces integration & marketing partnership with Aris Global introducing agCapture, an Integrated EDC Solution with Seamless Interoperability to CTMS for End-to-End Clinical Trials Management
Industry leaders combine forces to offer a cost-effective alternative for capturing and managing clinical research data.
AT THE 45th ANNUAL DIA CONFERENCE (SAN DIEGO, CA) — June 22, 2009: InferMed Limited, the leading global provider of advanced decision support and data-capture solutions for clinical research and practice, today announces the introduction of agCapture, an integrated EDC solution that offers life science organizations a cost-effective alternative for capturing, managing and reporting clinical research data. The eClinical offering is based on a reseller and integration agreement between InferMed Limited and Aris Global, the leading provider of software solutions for the life sciences industry, and is being marketed under the rebranded name, agCapture.
During the DIA 45th Annual Meeting, InferMed will be demonstrating and presenting agCapture in both the Aris Global booth #521and at the Microsoft booth # 931in the San Diego Convention Center.
agCapture is an industry-proven EDC system, developed by InferMed, which seamlessly integrates with ARISg, the market-leading pharmacovigilance system from Aris Global, enabling companies to reduce the efforts required for SAE reconciliation and immediately take the necessary steps for case processing. agCapture provides interoperability with clinical systems such as central labs, ePRO, interactive voice response systems (IVRS), and clinical trial management systems, including Aris Global’s agClinical, to help easily manage complex trials from end to end. A number of intuitive, interactive tools for study definition, online and off-line remote data entry, and remote study monitoring simplify study setup and shorten the time to database closure. Service offerings include study setup, training, integration with third-party software, and 24x7x365 multi-language support for investigators.
“Aris Global and InferMed have joined forces to effectively address the needs of life science organizations to keep their global trials on track, on budget, and on time,” said Simon Sparkes, vice president, corporate strategy and marketing, Aris Global. “With this joint offering, companies benefit from having a proven EDC solution that has been deployed worldwide in hundreds of sites and studies, is interoperable with third-party clinical and pharmacovigilance systems, and is backed by the stability, leadership and responsive support that Aris Global has been delivering for more than 20 years.”
“This partnership is a great step forward for the industry overall. Companies will now be able to conduct all data management activities electronically and be integrated with other systems and departments, such as safety and CTMS,” added Duane Lawrence, CEO, InferMed Limited. “The level of interoperability and integration that agCapture offers will appeal to organizations that want to eliminate waste and errors in duplicate data entry, and prevent delays and inefficiencies in adverse event reporting.”
Delivered as a hosted Software-as-a-Service offering, agCapture will also help reduce costs by eliminating the investment in new software, hardware, or new application and infrastructure support staff. The joint solution is offered at a pricing level that is specifically designed to accommodate a rapid introduction, making it affordable for companies looking to get started quickly, reduce costs and stay within set budgets.
About Aris Global
Aris Global (www.arisglobal.com) is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. More than 300 life science organizations rely on the company’s advanced solutions for maintaining regulatory compliance, managing and mitigating risk, improving operational efficiency and easily sharing information on a global basis.
About InferMed Limited
Formed in 1999, InferMed has become a global leader in providing software and services to the healthcare, pharmaceutical, and clinical research sectors. The company offers a range of highly innovative software solutions for collecting and managing data. Both through its MACRO EDC application and Arezzo® decision support technology, InferMed’s products are designed to improve patient outcomes and deliver drugs and therapies to healthcare providers more efficiently.
# # #
ARISg, agClinical, and agCapture are trademarks of Aris Global. Other product or company names mentioned herein are the trademarks of their respective owners.
Contact:
InferMed Limited
Phone: +44 2072917410
Fax: +44 2072917489
If you wish to receive further information on this news item, please contact us
Click here to return to the InferMed site